Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

AnchorMan LAAO Device Matches Up Well With the Watchman

News Conference News EuroPCR 2023

AnchorMan LAAO Device Matches Up Well With the Watchman

May 19, 2023

ADALA: Low-Dose Apixaban Tops DAPT After LAA Closure

News Conference News EuroPCR 2023

ADALA: Low-Dose Apixaban Tops DAPT After LAA Closure

May 18, 2023

Low Dose Direct Oral Anticoagulation vs. DAPT after LAAO - ADALA Trial

Presentation EuroPCR 2023

Low Dose Direct Oral Anticoagulation vs. DAPT after LAAO - ADALA Trial

Presenter: Xavier Freixa

May 17, 2023

Amplatzer Amulet LAA Closure Device Reduces Stroke Through 2 Years: Global Registry

News Conference News EuroPCR 2019

Amplatzer Amulet LAA Closure Device Reduces Stroke Through 2 Years: Global Registry

May 31, 2019

EWOLUTION Analysis Backs LAA Closure in High-Risk Patients Taking DAPT, Not Warfarin, After Procedure

News Conference News EuroPCR 2017

EWOLUTION Analysis Backs LAA Closure in High-Risk Patients Taking DAPT, Not Warfarin, After Procedure

Michael O'Riordan

May 24, 2017

LAA Occlusion vs Standard Care In Patients With Atrial Fibrillation And Intracerebral Hemorrhage

Presentation EuroPCR 2016

LAA Occlusion vs Standard Care In Patients With Atrial Fibrillation And Intracerebral Hemorrhage

Presenter: Jens Erik Nielsen-Kudsk

May 20, 2016

News Conference News EuroPCR 2016

LAA Closure May Provide Solution for Stroke Prevention in Patients With Prior Intracerebral Hemorrhage

Yael L. Maxwell

May 18, 2016

News Conference News EuroPCR 2016

EWOLUTION Confirms Safety, Efficacy for Real-World Use of Watchman, Even With No Postprocedural Drug Therapy

Yael L. Maxwell

May 17, 2016

News Conference News EuroPCR 2016

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

May 16, 2016

News Conference News EuroPCR 2014

Benefit of LAA Closure Becomes Most Evident After 1 Year

May 23, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.